Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's medicaid program

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 1, 2011, Pages 79-84

  Constantine, Robert J ^a   Tandon, Rajiv ^b   McPherson, Marie ^a   Andel, Ross ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; EARLY DIAGNOSIS; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAID; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRESCHOOL CHILD; PRESCRIPTION; PSYCHOSIS; PSYCHOTHERAPY; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD, PRESCHOOL; FEMALE; FLORIDA; HUMANS; MALE; MEDICAID; MENTAL DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 79951534822     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0068     Document Type: Article

References (24)

1. Constantine R: The use of antipsychotic medications among children 0-5 and 6-10 years old in Florida's Medicaid program. 2010. Retrieved from: www.flmedicalsbh.flmhi.usf.edy. Last accessed November 3, 2010.
2. Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA: Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr 6:79-83, 2006. (Pubitemid 43960577)
3. Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA: New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med 158:753-759, 2004. (Pubitemid 39025073)
4. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhorta AK: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. J Am Med Assoc 302:1765-1773, 2009.
5. Coyle J: Psychotropic drug use in very young children. J Am Med Assoc 283:1059-1060, 2000. (Pubitemid 30112223)
6. Domino ME, Swartz MS: Who are the new users of antipsychotic medications? Psychiatr Serv 59:507-514, 2008.
7. Gleason MM, Egger LH, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH: Psychopharmacological treatment for very young children: Contexts and guidelines. J Am Acad Child Adolesc Psychiatry 46:1532-1572, 2007. (Pubitemid 350146520)
8. Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M: Management of psychiatric disorders in children and adolescents with atypical antipsychotics: A systematic review of published clinical trails. Eur Child Adolesc Psychiatry 16:104-120, 2007. (Pubitemid 46643895)
9. Kalverdijk LJ, TobiH, van den Berg PB, Wagenaar L, Minderaa RB, de Jong-van den Berg LTW: Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Pyschiatr Serv 59:554-560, 2008.
10. Laita P, Cifuentes A, Doll A, Llorente C, Corts I, Parellada M, Moreno D, Ruiz-Sancho A, Graell M, Arango C: Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents. J Child Adolesc Psychopharmacol 17:487-501, 2007. (Pubitemid 47417776)
11. McClellan J, Werry J: Evidence-based treatments in child and adolescent psychiatry: An inventory. J Am Acad Child Adolesc Psychiatry 42:1388, 2003.
12. McCracken J, McGough J, Shah B, Cronin P, Hong D, Aman M, Arnold L, Lindsay R, Nash P, Hollway J: Risperidone in children with autism and serious behavioral problems. N Engl J Med 347: 314, 2002.
13. National Drug Codes Directory: U.S. Food and Drug Administration: Center for Drug Evaluation and Research 2008. Available at www.fda.gov/cder/ndc/ database/default.htm.
14. Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679-685, 2006. (Pubitemid 43848299)
15. Olfson M, Crystal S, Huang C, Gerhard T: Trends in antipsychotic drug use by very young, privately insured children. J Am Acad Child Adolesc Psychiatry 49:13-23, 2010.
16. Patel N, Crismon L, Hoagwood K: Trends in the use of typical and atypical antipsychotics in children and adolescents. J Acad Child Adolesc Psychiatry 44:548-556, 2005. (Pubitemid 40720954)
17. Patel NC, Crismon ML, Shafer A: Diagnoses and antipsychotic treatment among youths in a public mental health system. Ann Pharmacother 40:205-211, 2006. (Pubitemid 43269848)
18. Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML: Trends in anti-psychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol 12:221-229, 2002. (Pubitemid 35191348)
19. Rani F, Murray ML, Byrne PJ, Wong ICK: Epidemic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121:1002-1009, 2008.
20. Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M: A randomized, double-blind, placebo-controlled study of risper-idone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry 163:402-410, 2006. (Pubitemid 44469381)
21. Sikka R, Xia F, Aubert RE: Estimating medication persistency using administrative claims data. Am J Manag Care 11:449-457, 2005. (Pubitemid 41022729)
22. Vitiello B: Pediatric psychopharmacology and the interaction between drugs and the developing brain. Can J Psychiatry 43:582-584, 1998. (Pubitemid 28518686)
23. Vitiello B, Correll C, Van Zwieten-Boot B, Zudda A, Parellada M, Arango C: Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns. Eur Neuropsycho-pharmacol 19:629-635, 2009.
24. Zito JM, Safer DJ, Valluri S, Gardner JF, Korelitz JJ, Mattison DR: Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychopharmacol 17:195-203, 2007. (Pubitemid 46828915)